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Abstract
Background: The misdiagnosis of Plasmodium knowlesi by microscopy has prompted a re-evaluation of the
geographic distribution, prevalence and pathogenesis of this species using molecular diagnostic tools. In this
report, a specific probe for P. knowlesi, that can be used in a previously described TaqMan real-time PCR assay for
detection of Plasmodium spp., and Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and
Plasmodium ovale, was designed and validated against clinical samples.
Methods: A hydrolysis probe for a real-time PCR assay was designed to recognize a specific DNA sequence within
the P. knowlesi small subunit ribosomal RNA gene. The sensitivity, linearity and specificity of the assay were
determined using plasmids containing P. knowlesi DNA and genomic DNA of P. falciparum, P. knowlesi, P. malariae,
P. ovale and P. vivax isolated from clinical samples. DNA samples of the simian malaria parasites Plasmodium
cynomolgi and Plasmodium inui that can infect humans under experimental conditions were also examined
together with human DNA samples.
Results: Analytical sensitivity of the P. knowlesi-specific assay was 10 copies/μL and quantitation was linear over a
range of 10-106 copies. The sensitivity of the assay is equivalent to nested PCR and P. knowlesi DNA was detected
from all 40 clinical P. knowlesi specimens, including one from a patient with a parasitaemia of three parasites/μL of
blood. No cross-reactivity was observed with 67 Plasmodium DNA samples (31 P. falciparum, 23 P. vivax, six P. ovale,
three P. malariae, one P. malariae/P. ovale, one P. falciparum/P. malariae, one P. inui and one P. cynomolgi) and four
samples of human DNA.
Conclusions: This test demonstrated excellent sensitivity and specificity, and adds P. knowlesi to the repertoire of
Plasmodium targets for the clinical diagnosis of malaria by real-time PCR assays. Furthermore, quantitation of DNA
copy number provides a useful advantage over other molecular assays to investigate the correlation between
levels of infection and the spectrum of disease.
Background
The sensitivity and specificity of a diagnostic test define
the extent to which a pathogen can be effectively identi-
fied in a patient specimen. For malaria, the examination
of thin and thick blood smears by microscopy has been
the gold standard diagnostic method for over a century.
This test is simple to perform, requires only a micro-
scope and has a sensitivity of 50 parasites/μL [1]. The
parasitaemia can be quantified and the species of Plas-
modium identified based on parasite morphology. When
read by an experienced microscopist, the four major
species of human malaria (Plasmodium falciparum,
Plasmodium vivax, Plasmodium ovale and Plasmodium
malariae) can usually be discriminated.
However, a major pitfall of microscopy was recently
identified in the failure of this method to distinguish
between the benign P. malariae species and the poten-
tially lethal primate species Plasmodium knowlesi [2].
Zoonotic transmission of P. knowlesi from monkeys to
humans was previously only observed in sporadic cases
[3,4] and by blood passage from monkeys to humans
in laboratory controlled experiments [5-7] but was not
routinely detected by microscopic analysis of patient
specimens due to morphological similarities between P.
knowlesi and P. malariae [8]. As such, P. knowlesi was
not recognized as a cause of malaria in human popula-
tions, until recently. Using molecular diagnostic tools,
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